Vaxart, Inc. To Present At Leerink Partners Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today it will present at the Leerink Partners Global Healthcare Conference at The Waldorf Astoria Hotel in New York City.

Back to news